Rasagiline in treatment of Parkinson’s disease

Rasagiline (N-propargyl-1 (R)-aminoindan) is a novel propargylamine, irreversible, selective monoamine oxidase inhibitor for treatment of Parkinson’s disease (PD), a progressive condition associated with degeneration of dopaminergic neurons in the substantia nigra. Rasagiline inhibits striatal dopam...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Lakshmi, Henchcliffe, Claire
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515917/
https://www.ncbi.nlm.nih.gov/pubmed/18728823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515917/
https://www.ncbi.nlm.nih.gov/pubmed/18728823

Ejemplares similares